Rigel Pharmaceuticals

Aktienkurs
32.93
Täglich Wechseln
-1.69 -4.88%
Monatlich
-5.78%
Jährlich
49.14%
Q1 Prognose
33.68




Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Celldex Therapeutics USD -86.34M 13.54M 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Veracyte USD 42.31M 2.58M 2025-12


Rigel Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.